Literature DB >> 21208911

A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1).

Janice K Louie1, Meileen Acosta, Michael C Samuel, Robert Schechter, Duc J Vugia, Kathleen Harriman, Bela T Matyas.   

Abstract

BACKGROUND: many critically ill patients with 2009 pandemic influenza A (H1N1) (2009 H1N1) infection were noted to be obese, but whether obesity, rather than its associated co-morbidities, is an independent risk factor for severe infection is unknown.
METHODS: using public health surveillance data, we analyzed demographic and clinical characteristics of California residents hospitalized with 2009 H1N1 infection to assess whether obesity (body mass index [BMI] ≥ 30) and extreme obesity (BMI ≥ 40) were an independent risk factor for death among case patients ≥ 20 years old.
RESULTS: during the period 20 April-11 August 2009, 534 adult case patients with 2009 H1N1 infection for whom BMI information was available were observed. Two hundred twenty-eight patients (43%) were ≥ 50 years of age, and 378 (72%) had influenza-related high-risk conditions recognized by the Advisory Committee on Immunization Practices as risk factors for severe influenza. Two hundred and seventy-four (51%) had BMI ≥ 30, which is 2.2 times the prevalence of obesity among California adults (23%) and 1.5 times the prevalence among the general population of the United States (33%). Of the 92 case patients who died (17%), 56 (61%) had BMI ≥ 30 and 28 (30%) had BMI ≥ 40. In multivariate analysis, BMI ≥ 40 (odds ratio [OR], 2.8; 95% confidence interval [CI], 1.4-5.9) and BMI ≥ 45 (OR, 4.2; 95% CI, 1.9-9.4), age ≥ 50 years (OR, 2.1; 95% CI, 1.2-3.7), miscellaneous immunosuppressive conditions (OR, 3.9; 95% CI, 1.6-9.5), and asthma (OR, 0.5; 95% CI, 0.3-0.9) were associated with death.
CONCLUSION: half of Californians ≥ 20 years of age hospitalized with 2009 H1N1 infection were obese. Extreme obesity was associated with increased odds of death. Obese adults with 2009 H1N1 infection should be treated promptly and considered in prioritization of vaccine and antiviral medications during shortages.

Entities:  

Mesh:

Year:  2011        PMID: 21208911     DOI: 10.1093/cid/ciq152

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  165 in total

1.  Diesel exhaust exposure and nasal response to attenuated influenza in normal and allergic volunteers.

Authors:  Terry L Noah; Haibo Zhou; Hongtao Zhang; Katie Horvath; Carole Robinette; Matthew Kesic; Megan Meyer; David Diaz-Sanchez; Ilona Jaspers
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

2.  Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary.

Authors:  Manjunath P Pai; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

3.  Influenza and obesity: will vaccines and antivirals protect?

Authors:  Melinda A Beck
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

4.  Body mass index and infectious disease mortality in midlife in a cohort of 2.3 million adolescents.

Authors:  G Twig; N Geva; H Levine; E Derazne; N Goldberger; Z Haklai; A Leiba; J D Kark
Journal:  Int J Obes (Lond)       Date:  2017-10-30       Impact factor: 5.095

5.  The antibody response to influenza vaccination is not impaired in type 2 diabetics.

Authors:  Patricia A Sheridan; Heather A Paich; Jean Handy; Erik A Karlsson; Stacey Schultz-Cherry; Michael Hudgens; Sam Weir; Terry Noah; Melinda A Beck
Journal:  Vaccine       Date:  2015-06-01       Impact factor: 3.641

6.  Excess body mass is associated with T cell differentiation indicative of immune ageing in children.

Authors:  G Spielmann; C A Johnston; D P O'Connor; J P Foreyt; R J Simpson
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

Review 7.  Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).

Authors:  Daniel J Raiten; Fayrouz A Sakr Ashour; A Catharine Ross; Simin N Meydani; Harry D Dawson; Charles B Stephensen; Bernard J Brabin; Parminder S Suchdev; Ben van Ommen
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

8.  Immune Function: Impact of Exercise and Nutritional Interventions.

Authors:  Marian L Kohut
Journal:  Am J Lifestyle Med       Date:  2016-02-15

9.  Antigen-specific H1N1 influenza antibody responses in acute respiratory tract infections and their relation to influenza infection and disease course.

Authors:  John Patrick Haran; David C Hoaglin; Huaiqing Chen; Edward W Boyer; Shan Lu
Journal:  J Clin Virol       Date:  2014-05-28       Impact factor: 3.168

10.  Influenza Vaccine is Protective Against Laboratory-confirmed Influenza in Obese Children.

Authors:  Michael A Smit; Hai-Lin Wang; Edward Kim; Noel Barragan; Grace M Aldrovandi; Alvin Nelson El Amin; Laurene Mascola; Pia S Pannaraj
Journal:  Pediatr Infect Dis J       Date:  2016-04       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.